First-line bevacizumab in combination with chemotherapy for HER2-negative metastatic breast cancer: Pooled and subgroup analyses of data from 2447 patients

  1. Miles, D.W.
  2. Diéras, V.
  3. Cortés, J.
  4. Duenne, A.-A.
  5. Yi, J.
  6. O'Shaughnessy, J.
Journal:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Year of publication: 2013

Volume: 24

Issue: 11

Pages: 2773-2780

Type: Article

DOI: 10.1093/ANNONC/MDT276 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus